These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12857964)

  • 1. Regulation, counter-regulation, and immunotherapy of autoimmune responses to immunologically privileged retinal antigens.
    Caspi RR
    Immunol Res; 2003; 27(2-3):149-60. PubMed ID: 12857964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating of ocular inflammation with macrophage migration inhibitory factor is associated with notch signalling in experimental autoimmune uveitis.
    Yang H; Zheng S; Mao Y; Chen Z; Zheng C; Li H; Sumners C; Li Q; Yang P; Lei B
    Clin Exp Immunol; 2016 Feb; 183(2):280-93. PubMed ID: 26400205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Contribution of immunologic mechanisms in endogenous uveitis].
    Kubicka A
    Klin Oczna; 1995; 97(3-4):90-2. PubMed ID: 7474804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.
    Caspi RR; Roberge FG; Chan CC; Wiggert B; Chader GJ; Rozenszajn LA; Lando Z; Nussenblatt RB
    J Immunol; 1988 Mar; 140(5):1490-5. PubMed ID: 3346541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The suppression of the experimental autoimmune uveoretinitis with retinal S antigens by intranasal tolerance induction].
    Zheng YZ; Yuan LL; Lin JY; Li HQ
    Zhonghua Yan Ke Za Zhi; 2006 Dec; 42(12):1118-22. PubMed ID: 17415971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of experimental autoimmune uveitis in Lewis rats by oral administration of recombinant Escherichia coli expressing retinal S-antigen.
    Singh VK; Anand R; Sharma K; Agarwal SS
    Cell Immunol; 1996 Sep; 172(2):158-62. PubMed ID: 8964076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneously relapsing-remitting experimental autoimmune uveitis in rats allows successful therapeutic oral tolerance induction in ongoing disease.
    Huber A; Diedrichs-Möhring M; Wildner G
    Mol Immunol; 2015 Feb; 63(2):215-26. PubMed ID: 25085538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bench to bedside: new approaches to the immunotherapy of uveitic disease.
    Nussenblatt RB
    Int Rev Immunol; 2002; 21(2-3):273-89. PubMed ID: 12424847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rodent models of experimental autoimmune uveitis.
    Agarwal RK; Caspi RR
    Methods Mol Med; 2004; 102():395-419. PubMed ID: 15286397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proctor Lecture. Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications.
    Nussenblatt RB
    Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3131-41. PubMed ID: 1748544
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental autoimmune uveoretinitis (EAU)-related tissue damage and angiogenesis is reduced in CCL2⁻/⁻CX₃CR1gfp/gfp mice.
    Zhao J; Chen M; Xu H
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7572-82. PubMed ID: 25342612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of αA-Crystallin in Experimental Autoimmune Uveitis.
    Wang L; Zhang L; Wang ZF; Huang ZX; Hu X; Gong L; Tang X; Liu F; Luo Z; Ji W; Hu WF; Woodward Z; Zhu J; Liu YZ; Nguyen QD; Li DW
    Curr Mol Med; 2015; 15(6):558-64. PubMed ID: 26238368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
    Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
    J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic expression of an immunologically privileged retinal antigen extraocularly enhances self tolerance and abrogates susceptibility to autoimmune uveitis.
    Xu H; Wawrousek EF; Redmond TM; Nickerson JM; Wiggert B; Chan CC; Caspi RR
    Eur J Immunol; 2000 Jan; 30(1):272-8. PubMed ID: 10602050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible immune regulation following autoimmune disease in the immune-privileged eye.
    Kitaichi N; Namba K; Taylor AW
    J Leukoc Biol; 2005 Apr; 77(4):496-502. PubMed ID: 15647326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiome and Autoimmune Uveitis.
    Horai R; Caspi RR
    Front Immunol; 2019; 10():232. PubMed ID: 30837991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intraocular inflammation and homeostasis of the eye].
    Mochizuki M
    Nippon Ganka Gakkai Zasshi; 2009 Mar; 113(3):344-77; discussion 378. PubMed ID: 19348183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse models of experimental autoimmune uveitis.
    Caspi RR; Silver PB; Luger D; Tang J; Cortes LM; Pennesi G; Mattapallil MJ; Chan CC
    Ophthalmic Res; 2008; 40(3-4):169-74. PubMed ID: 18421234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental autoimmune uveitis and other animal models of uveitis: An update.
    Bansal S; Barathi VA; Iwata D; Agrawal R
    Indian J Ophthalmol; 2015 Mar; 63(3):211-8. PubMed ID: 25971165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the ICOS/B7RP-1 T cell costimulatory pathway in murine experimental autoimmune uveoretinitis.
    Usui Y; Akiba H; Takeuchi M; Kezuka T; Takeuchi A; Hattori T; Okunuki Y; Yamazaki T; Yagita H; Usui M; Okumura K
    Eur J Immunol; 2006 Nov; 36(11):3071-81. PubMed ID: 17039566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.